Elevated Blood Counts Flashcards Preview

Heme Week 2 > Elevated Blood Counts > Flashcards

Flashcards in Elevated Blood Counts Deck (45)
Loading flashcards...
1

What myeloproliferative diseases can cause neutrophilia?

-CML
-PV
-ET
-Myelofibrosis

2

What are some non-myeloproliferaitve causes of neutrophilia?

-cigarette use
-obesity
-drugs (corticosteroids/lithium)
-infection/inflammation
-malignancy

COD-MIM

3

What are some causes of increased platelets?

-inflammation
-trauma
-malignancy
-iron deficiency
-splenectomy
-myeloproliferative neoplasm (ET/MF/PV/CML-all of them)

ITS-MIM

4

What are myeloproliferative neoplasms?

hematopoietic neoplasms in which a clone of cells is mutated early in the differentiation of blood cells, such that these cells can differentiate fully into red cells, platelets and neutrophils, BUT no longer are well controlled in number, thus producing too many of one or more cell lines with fairly normal appearing and fairly normal functioning cells.

5

Central to MPNs is what?

understanding of the EPO receptor that is a JAK/STAT system which uses JAK-2 kinase

6

Mutated JAK2 kinase leads to what?

continuously active EPO pathway with or without EPO presence

7

A JAK2 mutation is most common in which MPN?

PV (90+%)

ET and Primary MF may have JAK2 mutation in up to 60% of cases and if they don't, they have a mutation in MPL (TPO receptor) or CALR (calreticulin)

8

What happens in PV?

too many red cells which leads to increased plasma volume, dilation of the veins, and other symptoms

9

What are the most common physical findings of PV?

From most to least:
-splenomegaly
-skin plethora
-conjunctival plethora
-engorged retinal vessels
-hepatomegaly
-hypertension (systolic high more often)

H-CHESS

10

What are the most common symptoms of PV?

-headache
-weakness
-pruritus
-dizziness
-diaphoresis (excess sweating)
-visual disturbances
-weight loss
-parethesias

PV hurts 2 people, dogs, and daughters

11

What are common complications/causes of death in PV patients?

-thrombosis/embolism (very common)
-progression to AML
-progression to myelofibrosis (become pancytopenic)

12

What is the median survival time from start of treatment (phlebotomy) in PV patients?

14 yrs

13

What is commonly seen in a PV blood smear?

-too many platelets
-hypochromic microcytic cells due to iron deficiency (GI blood loss is common)

14

What does the bone marrow look like in PV patients?

-very hyper cellular
-clusters of megakaryocyes

15

What are some risk factors for thrombosis in PV patients?

-age 65+
-previous thrombosis
-WBC 15K+
-CV risks
-Elevated HCT

W-CAPE

16

How is PV diagnosed?

1) Hemoglobin greater than 18.5+ in men, 16.5 in women
2) Presence of JAK2617V mutation or JAK2 exon 12 mutation
3) EPO below normal range

17

How is PV treated?

1) Phlebotomy
Target HCT 45% (prevents thrombosis well)

2) Aspirin
100 mg/d significantly lowers combined risk of CV death, non-fatal myocardial infarction, non-fatal stroke, major thromboembolism (hazard ratio 0.4). Relative risk increase in major bleeding with ASA 1.6.

3) Hydroxyurea
Very effective in reducing thrombosis (1.6% vascular events/yr vs 10.7%)
Target HCT of 45 with WBC >3000, supplement with phlebotomies if needed
No clear increase in leukemic transformation

4) Interferon
3 million units/d until response and then lower
Peg-interferon 0.5 mcg/kg weekly increased to 1.0 if no response in 12 weeks
Blood 112:8 3065—35/40 CR at I year
Can control platelets and HCT in Majority of patients and reduce spleen size and alleviate pruritus
May work when Hydrea fails
Busulfan reasonable in elderly patients

5) JAK2 inhibitors

P-HAJI

18

Symptoms of ET:

-erythromelalgia (severe burning pain of the forefoot)

19

What is commonly seen in the bone marrow (and sometimes the blood smear) in ET?

large numbers of megakaryocytes

20

How is ET diagnosed?

Platelets elevated (450 K/ul) without red cell elevation or iron deficiency and positive JAK2 mutation. IF JAK2 not positive, look in bone marrow for MPL or calreticulin mutation

21

If platelets get above 1.5 million, what can happen?

they may acquire vmF diseases with loss of large vFM multimers resulting in bleeding (purpura)

22

For major bleeding events in ET (can happen), what is the treatment?

- Correct thrombocytosis
- Withdraw aspirin

23

What is the treatment for ET?

need to reduce platelets:
-Hydroxyurea (affects all cell lines-leads to pancytopenia)
-Anagredile
-Interferon (pregnancy risk)

HAI

24

What does Anagredile do?

inhibits megakaryocytes= less platelets

25

Side effects of Anagredile?

-increased arterial thrombosis risk
-major bleeding
-myelofibrotic transformation

BAM

only used when Hydroxyurea not working

26

What are the criteria for "high risk" for ET and should be treated with platelet reduction?

- 60+ y/o
- platelets above 1500K/ul
- previous thrombosis, erythromelagia
-diabetes/HTN

APED-1500

27

What happens in primary MF?

fibrosis in BM, hematopoiesis is crowded out and moves to spleen and liver thus producing splenomegaly

28

What other MPN causes splenomegaly?

CML

29

What are some common findings in primary MF?

-hepatosplenomegaly
-fatigue and anemia
-leukocytosis
-thrombocytosis or -penia

H-FLAT

30

MF can also arise from other things and is called 'secondary' MF. What neoplastic conditions can lead to secondary MF?

-PV, CML
-acute megakaryoblastic leukemia
-myelodysplasia with fibrosis
-many more

PAM-CML